Helpline 07939 046 030

Emily Owen My Name is NF2

21 May 2019

Emily Owen My Name is NF2

My name is NF2. Well, Emily’s NF2. Us NF2s are all different. I guess you could say we have different specialities, different ways of making our presence felt.

Being Emily’s NF2 often feels as though I’m in a battle.  I want to be boss, but so does she; so we fight it out, every day. Sometimes Emily wins. She wins more often than I’d like, to be honest. But sometimes I win. It’s great when I win: then it’s impossible for Emily to ignore me. I hate being ignored, I like to be the centre of attention. But Emily ignores me a lot, even when I try really hard to make her acknowledge me. 

A secret among us NF2s is that, deep down, we have a grudging admiration for our people. They’re pretty tough, to cope with all we throw at them (but don’t tell anyone I said so).

Anyway, that’s enough about the people, let’s get back to me. I thought I’d tell you about my day.  Not a specific day, just a day. It could be any day…

6am I like to wake Emily early these days. She used to sleep for longer than she does now but, once I’d cottoned on to that, I realised I should wake her. The best way to do that is with her eyes. I don’t mean forcing her eyelids open, her eyes don’t close properly since her surgeries anyway, I mean by making her eyes sore. Emily’s eyes are really dry and, by 6 am, I can be pretty sure that the soothing cream she applied before she went to sleep will have gone. So, when she wakes, it’s not only early but she’s also in pain. And not just from her eyes. Her back and legs hurt, too.  2-0 to me.

9.30 am I know Emily wants to work on some of her writing today, so that makes my plan for the day easy: mess around with her ability to focus and concentrate. Since her brain surgeries – and I have to say, I’m pretty proud of my efforts here – Emily’s memory and concentration span are a shadow of their former selves. 3-0 to me.

12.30 pm Well, what a rubbish morning. I tried really hard but nothing worked. Emily ignored me and got on with what she was doing. 3-1 but at least I’m still winning and now it’s lunchtime. I’ll score a few easy points here, as Emily finds eating difficult. She has done ever since one of her surgeries. A surgery which, I might add, was all because of me. Better make that 4-1.

1 pm Emily is looking at food and rejecting it. This is great! She can’t eat bread, cake, crisps, sandwiches etc very easily at all. When she was eating a muffin once, she choked so badly that her Mum had to perform the Heimlich manoeuvre on her. 5-1. Now Emily knows what she can eat, though, so eating is not too much of a problem most of the time. I’d better give her a point for that, I suppose. 5-2.

5 pm I feel better after my failure this morning. Emily tried to carry on writing this afternoon but her concentration vanished; by which I mean, I took it. 6-2. To be fair, though, Emily did stop trying to write before she got too frustrated with her brain. She never used to manage that, which meant more points for me as she got angrier with herself. So I’ll give her 2 points I think. I may be in competition with her but credit where credit is due. 6-4.

Instead of writing, Emily decided to go for a walk. She forgot to take her crutches but thankfully I managed to make her nearly fall over as she left the house, which reminded her to get them. She doesn’t need her crutches indoors but she does outside. Since surgeries (yes, credit to me again), Emily can’t walk too well. Her legs are weak and her balance is poor. I know she wishes she didn’t need crutches at all. Or the wheelchair she sometimes uses. Which makes it what, 8-4 to me?

6 pm Emily’s niece wanted to sing a song to her. Massive win for me: Emily can’t hear since her surgeries. 9-4.

But then, unbelievably, her niece sang the song in sign language, so Emily could understand. 9-5.

I hate it that Emily has so many people helping her beat me. It’s not fair: she has medics, friends, family, strangers. Nearly everyone Emily and I meet is nice. Well, they’re nice to her. Mostly they ignore me. Except the medics, but that doesn’t really count, as I’m their job. But even they see Emily more than me. Worse than that, Emily does too. She didn’t used to. I used to win every day. But I don’t now. I win some days. But they are becoming fewer. And today is not one of them. Even I have to admit that Emily and all the people who help her, together, deserve 5 points. At least. So it’s 10-9 to her.

You know what I heard Emily say to someone the other day?

“My name is Emily and I have NF2.” I couldn’t believe it. What happened to, “I have NF2 and my name is Emily”?

She puts herself before me now. I try to eclipse her but she won’t let me. And I can’t bring myself to give her a point for that.

10-9. I lost today, but maybe I’ll do better tomorrow. I hope so but, the thing is, I have a feeling I won’t. Not if Emily has anything to do with it. In fact, between you and me, I’m beginning to wonder whether I ever really win at all.

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK